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Inadequate prescriptions are one of the biggest causes of adverse events related to medications. The 
aim of this study was to evaluate rational drug prescribing for elderly inpatients. A cross-sectional 
study was conducted to monitor the quality of drug prescriptions of patients admitted from May to 
August 2009, in a cardiovascular ward in Brazil. The quality evaluation of drug prescribing for elderly 
inpatient medication appropriateness was assessed by detection of potentially inappropriate 
medications, therapeutic duplicity and drug interactions. A total of 62 elderly inpatients were included, 
71% were female, median age was 77.5 years. Number of medications prescribed was 3818, ranging 
from 3 to 25 medications per prescription. Polypharmacy was highly common (86%) in analyzed 
prescriptions. 370 prescriptions were analyzed (6 prescriptions per patient). We reviewed 370 
medication orders (3818 prescribed drugs), 34% of which had at least one potentially inappropriate 
medication for the elderly, 70% presented therapeutic duplicity. Drug interactions were detected in 77% 
of prescriptions. Positive associations were observed between therapeutic duplicity and potentially 
inappropriate medications and between therapeutic duplicity and severe drug interactions. Our study 
show high rate of inappropriate prescriptions, which can influence the effectiveness of 
pharmacotherapy as much as the elderly safety.  
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INTRODUCTION 
  
During the last century various factors contributed to the 
situation of worldwide population aging, among which 
stands out the socio-economic progress that has been 
implicated in the change of conditions of people’s living 
and in the incorporation of new technologies (Fernandez-
Llimos et al., 2005). This increment in life expectation 
leads to a greater prevalence of chronic diseases and the 
increase in demand for care and technologies in health, 
with emphasis on the utilization of medications 
(Spinewine et al., 2007). 
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On the other hand, inadequate use of medications is 
considered as a risk factor to health, in view that it 
provokes an elevated rate of morbid-mortality throughout 
the world (Fernandez-Llimos et al., 2004; Hustey, 2008). 
In this situation, inadequate prescriptions present a high 
potential for medication interactions, medications 
potentially inadequate, and therapeutic duplicity 
(Spinewine et al., 2007; Ryan et al., 2009; Gurwitz et al., 
2003). It is worth emphasizing that these prescriptions 
are one of the biggest causes of adverse events related 
to medications and that they increase the probability of 
occurrence in the elderly, especially in the presence of 
polypharmacy (Bergman et al., 2007).   
Some other important information is that the elderly 
population presents multiple clinical conditions 
associated       to     chronic     diseases,    utilizing   more  
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medications for treating them when compared to younger 
populations (Spinewine et al., 2007; Bressler and Bahl, 
2003). Therefore, the risk of inadequate prescriptions is 
increased in this age group. Adding to this, there are 
physiological changes linked to age that altering the 
pharmacokinetics and pharmacodynamic characteristics, 
affecting the absorption, distribution, metabolism, and 
excretion of drugs, which makes this population even 
more fragile (Mallet et al., 2007). 
Faced with such particularities, it is necessary to 
reduce the incidence and prevalence of adverse events 
related to inappropriate prescriptions in the elderly, 
mainly because the greater part of these events are 
preventable (Lisby et al., 2005). In the last years, studies 
carried out in Brazil showed a high consumption of 
inappropriate drugs by elderly (Aguiar et al., 2008; 
Ribeiro et al., 2008; Nassur et al., 2010). From this 
perspective, the aim of this study was to evaluate rational 
medication prescribing for elderly inpatients.  
 
 
MATERIALS AND METHODS 
 
Setting  
 
This study took place in a private hospital located in the city of 
Aracaju – SE, Northeastern Brazil. This medium-sized 125-bed 
hospital of high complexity is a reference center for hospital medical 
care in the State; furthermore, it is linked to teaching institutions 
and acts as a school hospital. 
 
 
Study design 
 
This was a cross-sectional study that was conducted to monitor the 
quality of prescriptions of patients admitted from May to August 
2009. Since data collection was performed daily, from Monday to 
Friday, weekends’ prescriptions were excluded, as well as 
inpatients who did not receive pharmacotherapy. 
 
 
Population 
 
Adult inpatients (> 65 years of age) admitted in the hospitalization 
ward during the period of study which the main diagnosis was 
coded into “Diseases of the circulatory system” category – 
according to 10th international classification of diseases (ICD-10) of 
the world health organization (WHO)  were included in the study. 
 
 
Data collection 
 
Data were collected through a structured form developed by the 
researchers based on related literature (WHO, 2001).  In order to 
standardize data collection, field researchers were trained and 
supervised during a 15 day pilot study. 
 
 
Prescription analysis 
 
Physicians' prescriptions were evaluated in agreement with the 
literature (Chrischilles et al., 2009). Rationality of pharmacotherapy 
is related to quality, safety, and cost-effectiveness: 
 
 
 
 
1. Potentially inappropriate medications: are drugs with unfavorable 
benefit to risk ratio when other safer or more efficient therapeutic 
alternatives are available. They were investigated according to the 
most recent review of Beers criteria (Fick et al., 2003). 
2. Therapeutic Duplicity: is the use of two or more drugs of the 
same therapeutic class for the same clinical condition. In this study, 
the anatomical-therapeutic-chemical (ATC) Classification was 
utilized as a tool for determining therapeutic class (WHO, 2009). 
3. Potential drug-drug interactions were assessed using the 
Micromedex® Drug-Reax® system.  Drug interactions were 
categorized as ‘major’, ‘moderate’ or ‘minor’, according to the 
severity. Micromedex® defines ‘major’ may be life threatening 
and/or require medical intervention to minimize or prevent serious 
adverse effects. ‘Moderate’ interactions may result in exacerbation 
of the inpatient’s condition and/or require an alteration in therapy. 
Finally, ‘minor’ interactions would have limited clinical effects. 
Manifestations may include an increased in the frequency or 
severity of the side effects but generally would not require a major 
alteration in therapy.  
 
 
Statistical analysis 
 
Analysis was performed using SPSS 17.0 (SPSS Inc., Chicago, 
U.S.A.). The statistical analysis was performed using the Chi-
Square test with an assumption that p value ≤ 0.05 is significant. 
 
 
Ethical issues 
 
This study was approved by the Research Ethics Committee and 
authorized by the directors of study hospital. The purpose of the 
present work was neither to find out nor to identify the professional 
that committed the flaw, but to analyze and detect the prescription 
errors, making the medication system safer for its users. Therefore, 
the collected data was used exclusively by the researchers, 
guaranteeing the privacy of the information obtained. 
 
 
RESULTS 
 
A total of 62 elderly inpatients had their prescriptions 
analyzed, 44 (71%) were female, age varied from 65 to 
94 years (median age 77.5 years) (Table 1). There was a 
positive association between frequency of prescriptions 
and female gender, and age. The most consumed drugs 
were those for Cardiovascular System (25, 7%) and 
those for Alimentary and Metabolism Treatment (22, 6%) 
(Table 2). 
Number of medications prescribed was 3818 (median 
number per patient was 11), ranging from 3 to 25 
medications per prescription. Therefore, polypharmacy 
was highly common (86%) in analyzed prescriptions. 370 
prescriptions were analyzed (6 prescriptions per patient). 
According to measures of prescription quality proposed 
in this study, 1489 potential drug-drug interactions (DDIs) 
were detected in 77% of the prescriptions. The number of 
interactions per prescription varied from 1 to 20 with a 
median of 4 (Figure I).  Regarding DDI severity, 31% 
were classified as severe and 64% were considered as 
moderate. Some examples of severe DDI most  observed  
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Table 1. Characteristics of sample included in the study (Brazil, 2009). 
 
No. of patients 62 
Gender 
 
Females, n (%) 44 (71%) 
Male, n (n%) 18 (39%) 
 
 
Age  
 
Mean, years (SD) 77.5 (7.8) 
Min-Max, years 65 - 94 
 
 
 
Table 2. Distribution of drugs used by elderly (n = 3818), according to the Anatomical-Therapeutic-Chemical Classification System - 
ATC levels 1 and 2 (Brazil, 2009). * Absolute and relative frequencies calculated disregarding the drugs for which no classification 
was possible: n = 19. 
 
Categories Code Atc n % 
Cardiovascular system C 982 25.7 
Cardiac therapy C01 126  
Diuretics C03 247  
Peripheral vasodilators C04 14  
Vasoprotectives C05 59  
Beta blocking agents C07 142  
Calcium channel blockers C08 54  
Agents acting on the renin-angiotensin system C09 203  
Serum lipid reducing agents C10 137  
    
Alimentary tract and metabolism A 865 22.6 
Antacids/ drugs for treatment of peptic ulcer/ flatulence  A02 286  
Antispasmodic and anticholinergic agents and propulsives A03 213  
Antiemetics And antinauseants A04 1  
Laxatives A06 80  
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents A07 40  
Drugs used in diabetes A10 245  
    
Nervous system N 633 16.5 
Analgesics N02 339  
Antiepileptics N03 78  
Anti-parkinson drugs N04 05  
Psycholeptics N05 100  
Psychoanaleptics N06 86  
Other nervous system drugs N07 25  
    
Blood and blood forming organs B 575 15.1 
Antithrombotic Agents B01 467  
Antianemic Preparations B03 56  
Blood substitutes and perfusion solutions B05 52  
Respiratory system R 339 8.8 
General antiinfectives for systemic use J 312 8.2 
Musculo-skeletal system M 33 0.9 
Systemic hormonal preparations,  excluding sex hormones and insulins H 60 1.6 
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Figure 1. Distribution of drug interactions analyzed by prescription in the period from May to August 2009, 
private hospital in Brazil. 
 
 
 
Table 3. Distribution of drug potentially inappropriate for the elderly (n = 116) (Brazil, 2009). 
 
Drugs Concern n % 
Amiodarone Associated with QT interval problems and risk of provoking torsades depointes. Lack 
of efficacy in older adults. 75 64.6 
    
Mineral Oil Potential for aspiration and adverse effects. Safer alternatives available. 28 24.1 
    
Diazepam 
These drugs have a long half-life in elderly patients (often several days), producing 
prolonged sedation and increasing the risk of falls and fractures. Short-and 
intermediate-acting benzodiazepines are preferred if a benzodiazepine is required. 
6 5.2 
    
Nifedipine Potential for hypotension and constipation. 5 4.3 
    
Amitriptyline Because of its strong anticholinergic and sedation properties, is rarely the 
antidepressant of choice for elderly patients. 2 1.7 
 
 
 
were: aspirin and warfarin, amiodaron and warfarin and 
clopidogrel and enoxaparin. 
The therapeutic duplicity was observed in 70% of the 
prescriptions. The therapeutic classes with the greatest 
percentage of duplicity were the antithrombotic (38.5%) 
and diuretic (22.3%) agents. Regarding the potentially 
inappropriate medication for the elderly, 31.3% of the 
prescriptions contained at least one drug considered 
inappropriate. Table 3 shows the distribution of drug 
potentially inappropriate for the elderly. 
Positive associations were observed between 
therapeutic duplicity and potentially inappropriate 
medications (p < 0.0001) and between therapeutic 
duplicity and severe drug interactions (p <0.0001). 
DISCUSSION 
 
Our    study   demonstrated    a   higher    frequency   of 
prescriptions in female gender, and older persons, as 
well a higher number of medications prescribed. These 
results corroborate that main risk factors to elderly when 
they receive an inappropriate prescription are of female 
gender, poorer in health status, and subjected to 
polypharmacy (Barry et al., 2008).  
Polypharmacy in the elderly population is a well-known 
problem and many studies have been carried out to 
quantify the extent of the problem (Gallagher et al., 2007; 
Schuler et al., 2008). Bergman et al. (2007) defined 
polypharmacy  as  the  concomitant  use  of  six  or  more  
  
 
 
 
medications, where affirm that the risk for inappropriate 
medication increased greatly at this threshold. Our results 
corroborate other studies (Schuler et al., 2008; Steinman 
et al., 2006), confirming that polypharmacy in the elderly 
is a rule and not an exception. According to Rollason and 
Vogt (2003), polypharmacy has many adverse 
consequences in this age group, among which DDIs are, 
the most common problem observed in our study. DDIs 
represent an important part of the problems related to 
medications and have been found in up to 15% of the 
elderly with polypharmacy (Radosevic et al., 2008).  
The prevalence of therapeutic duplicity in this study 
was higher than that reported by Schuler et al. (2008), 
which found that 7.6% of the prescriptions contained 
duplicity. The highest percentage is due to considerable 
number of medications prescribed by their brand name 
(Siqueira et al., 2011). Since prescribing using trade 
names implicate the risk of duplicate when the physician 
does not exactly know which drug or drug combinations 
are contained in the medication. Moreover, prescribing 
trade-name drugs implicates a higher probability of 
confusing look alike/sound alike drug names, thus 
prescribing a not indicated medication that could harm 
the patient.  
In general, the association of antithrombotic drugs 
reduces morbidity and mortality, however their adverse 
effects or their incorrect use may cause increase in the 
risk of bleeding, especially among older patients (Avezum 
et al., 2005). Clinical trial data indicate that diuretics are 
usually well tolerated and decrease progression of 
hypertension, incidence of stroke, coronary events and 
congestive heart failure (The ALLHAT Officers and 
Coordinators for the ALLHAT Collaborative Research 
Group, 2002). Nevertheless, higher doses have been 
shown to add minimal extra antihypertensive efficacy and 
are associated with hypokalemia and other adverse 
effects (Flack and Cushman, 1996). According to 
O’Mahony and Gallagher (2008), the optimisation of 
monotherapy within a single drug class should be 
observed prior to considering a new agent. 
The rate of prescriptions containing potentially 
inappropriate medications for the elderly in this study was 
similar to studies conducted in North America and 
Europe, which reported estimated prevalence rates 
ranging from 2.8 to 40.0% (Laurier et al., 2002; Onder et 
al., 2003; Heininger-Rothbucher et al., 2003). This large 
range in prevalence rates can be accounted by the 
different types of settings, sample sizes, study designs, 
data sources, and data collection periods.  
Although most studies of inappropriate prescriptions in 
elderly have focused on themes such as therapeutic 
duplicity, drug interactions and potentially inappropriate 
medications, the association between them has not been 
well studied. These data are important because Beers’ 
Criteria do not include severity of drug–drug interactions 
and make no reference to duplicity (Gray et al., 2003). 
In clinical routine, the physicians have an essential task 
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of rationalizing elderly prescriptions, preventing the 
negative aspects of polypharmacy (Wawruch et al., 
2007). According to Avorn (2004), the use of 
interdisciplinary teams to care for elderly patients may 
provide opportunities to substantially improve the quality 
and safety of drug therapy in this population. Such teams 
may include the involvement of nurse specialists, clinical 
pharmacists, and other health professionals, comple-
menting and extending the efforts of the physician. 
 
 
Study limitations 
 
There are limitations of this study. First, its monocentric 
and time-limited study design. We also exclusively 
recruited patients on cardiology/cardiovascular wards, 
excluding patients with other diseases. We also 
exclusively recruited patients on cardiology-
/cardiovascular wards, excluding patients with other 
diseases. However, as our primary focus was on quality 
prescribing, such limitation, which resulted in a specific 
range of drugs and treatment protocols, permitted a more 
accurate analysis of drug-drug interactions and 
potentially inappropriate medications under a clinical 
point of view. Therefore, we believe that the basic 
findings of this study can be extrapolated to related 
pathological conditions and associated assist modes. 
 
 
Conclusion 
 
Despite its limitations, the obtained data show low 
rationality of the prescriptions used by the elderly, 
possibly causing more harm than benefits. Therefore, we 
understand that the greatest challenge of health systems 
is training healthcare professionals to optimize the 
prescription’s rationality of elderly, assuring the 
effectiveness of treatments and the safety of this 
population that is growing worldwide. 
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